Lactagard 1500 Injection is a sterile, injectable antibiotic formulation combining Cefoperazone 1000 mg and Sulbactam 500 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefoperazone, a third-generation cephalosporin, exhibits potent bactericidal activity by inhibiting bacterial cell wall synthesis, effective against both Gram-positive and Gram-negative organisms. Sulbactam, a beta-lactamase inhibitor, enhances the efficacy of Cefoperazone by preventing enzymatic degradation by beta-lactamase-producing bacteria, thereby extending the antimicrobial spectrum. Lactagard 1500 is indicated for severe infections including lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and gynecological infections caused by susceptible organisms. The combination is particularly valuable in managing infections caused by resistant strains where beta-lactamase production is a concern. Administered via intravenous or intramuscular injection, dosing should be guided by the severity of infection, renal function, and clinical response. Caution is advised in patients with hypersensitivity to cephalosporins or penicillins. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and alterations in coagulation parameters. Lactagard 1500 Injection should be used under strict medical supervision with appropriate microbiological monitoring to optimize therapeutic outcomes and minimize resistance development.